Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Thyroid : Official Journal of the American Thyroid Association|February 24, 2007
Hürthle cell thyroid carcinoma metastatic to the sigmoid colonW Arnous, S Beltran, N Berger, et al.European Journal of Endocrinology|May 12, 2009
Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levelsF Bonnet, B Balkau, J M Malécot, et al.Endocrine-Related Cancer|July 18, 2018
ALK7 expression in prolactinoma is associated with reduced prolactin and increased proliferationM Principe, M Chanal, V Karam, et al.World Journal of Surgery|September 25, 2012
(18)F-FDG uptake at initial staging of the adrenocortical cancers: a diagnostic tool but not of prognostic valueL Tessonnier, C Ansquer, C Bournaud, et al.The Journal of Clinical Endocrinology and Metabolism|January 23, 2009
Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancerS Leboulleux, P R Schroeder, N L Busaidy, et al.The Journal of Clinical Endocrinology and Metabolism|October 6, 2012
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathyL Bartalena, G E Krassas, W Wiersinga, et al.Endocrine-Related Cancer|November 8, 2018
French Endocrine Society Guidance on endocrine side effects of immunotherapyF Castinetti, F Albarel, F Archambeaud, et al.Journal of Endocrinological Investigation|February 9, 2017
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?L Bartalena, G Veronesi, G E Krassas, et al.Pageof 2